Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis

Clinical and Vaccine Immunology

Volumn 16, Issue 7, 2009, Pages 1025-1032

  Parra, Marcela ^a   Yang, Amy L ^a   Lim, JaeHyun ^a   Kolibab, Kristopher ^a   Derrick, Steven ^a   Cadieux, Nathalie ^a   Perera, Liyanage P ^b   Jacobs, William R ^c   Brennan, Michael ^a,d   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Aeras Global TB Vaccine Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BCG VACCINE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6 85B FUSION PROTEIN; GAMMA INTERFERON; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 21; INTERLEUKIN 27; MODIFIED VACCINIA VIRUS ANKARA STRAIN ANTIGEN 85A; MODIFIED VACCINIA VIRUS ANKARA STRAIN ANTIGEN 85B; MODIFIED VACCINIA VIRUS ANKARA STRAIN ANTIGEN HSP65; MODIFIED VACCINIA VIRUS ANKARA STRAIN EARLY SECRETORY ANTIGENIC TARGET 6; MONOPHOSPHORYL LIPID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM MUTANT; CELL CULTURE; COCULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; EXPERIMENTAL MODEL; GROWTH INHIBITION; GROWTH REGULATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG TUBERCULOSIS; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION;

ANIMALS; COCULTURE TECHNIQUES; CYTOKINES; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 67650401102     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00067-09     Document Type: Article

References (36)

1. Bosio, C. M., and K. L. Elkins. 2001. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not defects in specific T-cell-mediated immunity. Infect. Immun. 69:194-203.
2. Brandt, K., P. B. Singh, S. Bulfone-Paus, and R. Ruckert. 2007. Interleukin- 21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev. 18:223-232. (Pubitemid 46891291)
3. Braunstein, M., B. J. Espinosa, J. Chan, J. T. Belisle, and W. R. Jacobs, Jr. 2003. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 48:453-464.
4. Cheon, S. H., B. Kampmann, A. G. Hise, M. Phillips, H. Y. Song, K. Landen, Q. Li, R. Larkin, J. J. Ellner, R. F. Silver, D. F. Hoft, and R. S. Wallis. 2002. Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin. Diagn. Lab. Immunol. 9:901-907.
5. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
6. + T cells mediate IFN-gammaindependent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J. Immunol. 171:4689-4699.
7. Cowley, S. C., and K. L. Elkins. 2003. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J. Exp. Med. 198:379-389.
8. Cowley, S. C., M. F. Goldberg, J. A. Ho, and K. L. Elkins. 2008. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain. J. Infect. Dis. 198:284-292.
9. Cowley, S. C., E. Hamilton, J. A. Frelinger, J. Su, J. Forman, and K. L. Elkins. 2005. CD4-CD8-T cells control intracellular bacterial infections both in vitro and in vivo. J. Exp. Med. 202:309-319.
10. + T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth. J. Immunol. 179:7709-7719.
11. Delogu, G., A. Li, C. Repique, F. Collins, and S. L. Morris. 2002. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect. Immun. 70:292-302.
12. Derrick, S. C., A. L. Yang, and S. L. Morris. 2004. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23:780-788.
13. Fine, P. E. 2001. BCG: the challenge continues. Scand. J. Infect. Dis. 33: 243-245.
14. Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinburgh) 84:93-101. (Pubitemid 38087953)
15. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
16. Hanekom, W. A., H. M. Dockrell, T. H. Ottenhoff, T. M. Doherty, H. Fletcher, H. McShane, F. F. Weichold, D. F. Hoft, S. K. Parida, and U. J. Fruth. 2008. Immunological outcomes of new tuberculosis vaccine trials: W. H. O. panel recommendations. PLoS Med. 5:e145.
17. Hinchey, J., S. Lee, B. Y. Jeon, R. J. Basaraba, M. M. Venkataswamy, B. Chen, J. Chan, M. Braunstein, I. M. Orme, S. C. Derrick, S. L. Morris, W. R. Jacobs, Jr., and S. A. Porcelli. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Investig. 117:2279-2288.
18. Hoft, D. F., S. Worku, B. Kampmann, C. C. Whalen, J. J. Ellner, C. S. Hirsch, R. B. Brown, R. Larkin, Q. Li, H. Yun, and R. F. Silver. 2002. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J. Infect. Dis. 186:1448-1457. (Pubitemid 35286112)
19. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521-531.
20. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688-698.
21. Lim, J., S. C. Derrick, K. Kolibab, A. L. Yang, W. R. Jacobs, and S. L. Morris. 2009. Post-infection characterization of early pulmonary cytokine and chemokine responses in mice immunized with TB vaccines and challenged by the aerosol route with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 16:122-126.
22. Lin, P. L., H. L. Plessner, N. N. Voitenok, and J. L. Flynn. 2007. Tumor necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc. 12:22-25.
23. Opie, E. L., and J. Freund. 1937. An experimental study of protective inoculation with heat killed tubercle bacilli. J. Exp. Med. 66:761-788.
24. Ordway, D., M. Henao-Tamayo, C. Shanley, E. E. Smith, G. Palanisamy, B. Wang, R. J. Basaraba, and I. M. Orme. 2008. Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 15:1248-1258.
25. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19:491-494. (Pubitemid 28518024)
26. Pearl, J. E., S. A. Khader, A. Solache, L. Gilmartin, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2004. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 173:7490-7496.
27. Perera, P. Y., S. C. Derrick, K. Kolibab, F. Momoi, M. Yamomato, S. L. Morris, T. A. Waldmann, and L. P. Perera. 2009. A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 27:2121-2127.
28. Robinson, C. M., and G. J. Nau. 2008. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J. Infect. Dis. 198:359-366.
29. Sada-Ovalle, I., A. Chiba, A. Gonzales. M. B. Brenner, and S. M. Behar. 2008. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLOS Pathog. 4:e1000239.
30. + T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. J. Immunol. 160:2408-2417.
31. Soares, A. P., T. J. Scriba, S. Joseph, R. Harbacheuski, R. A. Murray, S. J. Gelderbloem, A. Hawkridge, G. D. Hussey, H. Maecker, G. Kaplan, and W. A. Hanekom. 2008. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
32. Sterne, J. A., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2:200-207.
33. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, C. J. Saris, J. J. O'Shea, L. Hennighausen, M. Ernst, and C. A. Hunter. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-945.
34. World Health Organization. 2008. Global tuberculosis control: surveillance, planning, financing WHO/HTM/TB/2008.393. WHO, Geneva, Switzerland.
35. Worku, S., and D. F. Hoft. 2000. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin. Clin. Infect. Dis. 30(Suppl. 3):S257-S261.
36. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGFbeta are required for differentiation of human TH17 cells. Nature 454: 350-352.